Elias J. Jabbour

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (22)

Jayastu Senapati

Assistant professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Alex Bataller Torralba

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Ghayas C. Issa

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Rashmi Kanagal Shamanna

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Fadi Haddad

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

J. Bryan Iorgulescu

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Sanam Loghavi

UNITED STATES

View details

Oren Pasvolsky

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Qaiser Bashir

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Jan A. Burger

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Koichi Takahashi

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Koji Sasaki

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Nitin Jain

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Farhad Ravandi

Professor of Medicine, Chief Section of AML

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Nicholas J. Short

UNITED STATES

View details

Warren Fiskus

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

PRITHVIRAJ BOSE

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Josep Maria Ribera Santasusana

Chief of the Department

Institut Català d'Oncologia

SPAIN

View details

Courtney D. DiNardo

UNITED STATES

View details

Swaminathan P. Iyer

Professor of Medicine

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Musa Yilmaz

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Naval G. Daver

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Elias J. Jabbour

Research Interests

Explore related searches

Contact this professor

Articles (21)

Contemporary outcomes of octa‐nonagenarians with newly diagnosed acute myeloid leukemia

Barriers to allogeneic stem cell transplantation in responding patients with TP53-mutated acute myeloid leukemia

The evolving therapeutic revolution in adult acute lymphoblastic leukemia

Cytomolecular Mechanisms of Relapse and Post‐Relapse Outcomes After Frontline FLT3 Inhibitor‐Based Therapy in FLT3‐Mutated AML

Contemporary Outcomes of Adults With Acute Lymphoblastic Leukemia With KMT2A Rearrangements Treated With Immunotherapy‐Based Regimens

Management of chronic myeloid leukemia in 2025

Age-related prognoses of genetic subtypes in B-cell acute lymphoblastic leukemia/lymphoma (B-ALL): insights from a decade of national data

A Phase 2 Trial of CPX‐351 Combined With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia

Adult Acute Lymphoblastic Leukemia: 2025 Update on Diagnosis, Therapy, and Monitoring

Cladribine, idarubicin, and cytarabine (CLIA) for patients with relapsed and/or refractory acute myeloid leukemia: A single‐center, single‐arm, phase 2 trial

Safety and long‐term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single‐center phase 1,2 trial

Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplant

Phase I Results of Bromodomain and Extra-Terminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies

Management of chronic myeloid leukemia in 2023 – common ground and common sense

Ultrasensitive NGS MRD assessment in Ph+ ALL: Prognostic impact and correlation with RT‐PCR for BCR::ABL1

Association between bariatric surgery and outcomes in chronic myeloid leukemia.

Performance of IPSS‐M in patients with myelodysplastic syndrome after hypomethylating agent failure

Phase II study of cladribine, idarubicin, and ara‐C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia

Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation

Chimeric antigen receptor T-cell therapy for adult B-cell acute lymphoblastic leukemia: state-of-the-(C)ART and the road ahead

Philadelphia-Like Genetic Rearrangements in Adults With B-Cell ALL: Refractoriness to Chemotherapy and Response to Tyrosine Kinase Inhibitor in ABL Class Rearrangements

Collaborators (22)

Jayastu Senapati

Alex Bataller Torralba

Ghayas C. Issa

Rashmi Kanagal Shamanna

Fadi Haddad

J. Bryan Iorgulescu

Sanam Loghavi

Oren Pasvolsky

Qaiser Bashir

Jan A. Burger

Koichi Takahashi

Koji Sasaki

Nitin Jain

Farhad Ravandi

Nicholas J. Short

Warren Fiskus

PRITHVIRAJ BOSE

Josep Maria Ribera Santasusana

Courtney D. DiNardo

Swaminathan P. Iyer

Musa Yilmaz

Naval G. Daver

Make your next move.